In eukaryotic cells ATP is generated by oxidative phosphorylation, an energ
etic coupling at the mitochondrial level. The oxidative reactions occurring
in the respiratory chain generate an electrochemical proton gradient on bo
th sides of the inner membrane. This gradient is used by the ATPsynthase to
phosphorylate ADP into ATP. The coupling between respiration and ADP phosp
horylation is only partial in brown adipose tissue (BAT) mitochondria, wher
e the uncoupling protein UCP1 causes a reentry of protons into the matrix a
nd abolishes the electrochemical proton gradient. The liberated energy is t
hen dissipated as heat and ATP synthesis is reduced. This property was for
a long time considered as an exception and specific to the non-shivering th
ermogenesis found in BAT. The recent cloning of new UCPs expressed in other
tissues revealed the importance of this kind of regulation of respiratory
control in metabolism and energy expenditure. The newly characterised UCPs
are potential targets for obesity treatment drugs which could favour energy
expenditure and diminish the metabolic efficiency.
In 1997, we cloned UCP2 and proposed a role for this new uncoupling protein
in diet-induced thermogenesis, obesity, hyperinsulinemia, fever and restin
g metabolic rate. Currently, an abundant literature deals with UCP2, but it
s biochemical and physiological functions and regulation remain unclear. Th
e present review reports the status of our knowledge of this mitochondrial
carrier in terms of sequence, activity, tissue distribution and regulation
of expression. The putative physiological roles of UCP2 will be introduced
and discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.